Health Catalyst, Inc. (HCAT)
1.755
+0.06
(+3.24%)
USD |
NASDAQ |
Sep 14, 10:04
Health Catalyst Price to Book Value : 1.298 for Sept. 14, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 1.258 |
| September 10, 2026 | 1.28 |
| September 09, 2026 | 1.28 |
| September 08, 2026 | 1.258 |
| September 04, 2026 | 1.250 |
| September 03, 2026 | 1.265 |
| September 02, 2026 | 1.250 |
| September 01, 2026 | 1.265 |
| August 31, 2026 | 1.213 |
| August 28, 2026 | 1.176 |
| August 27, 2026 | 1.176 |
| August 26, 2026 | 1.176 |
| August 25, 2026 | 1.169 |
| August 24, 2026 | 1.176 |
| August 21, 2026 | 1.132 |
| August 20, 2026 | 1.206 |
| August 19, 2026 | 1.250 |
| August 18, 2026 | 1.265 |
| August 17, 2026 | 1.258 |
| August 14, 2026 | 1.369 |
| August 13, 2026 | 1.295 |
| August 12, 2026 | 1.324 |
| August 11, 2026 | 1.302 |
| August 10, 2026 | 1.273 |
| August 07, 2026 | 1.28 |
| Date | Value |
|---|---|
| August 06, 2026 | 1.709 |
| August 05, 2026 | 1.768 |
| August 04, 2026 | 1.687 |
| August 03, 2026 | 1.635 |
| July 31, 2026 | 1.546 |
| July 30, 2026 | 1.539 |
| July 29, 2026 | 1.598 |
| July 28, 2026 | 1.583 |
| July 27, 2026 | 1.591 |
| July 24, 2026 | 1.539 |
| July 23, 2026 | 1.487 |
| July 22, 2026 | 1.509 |
| July 21, 2026 | 1.554 |
| July 20, 2026 | 1.598 |
| July 17, 2026 | 1.665 |
| July 16, 2026 | 1.687 |
| July 15, 2026 | 1.724 |
| July 14, 2026 | 1.694 |
| July 13, 2026 | 1.694 |
| July 10, 2026 | 1.694 |
| July 09, 2026 | 1.657 |
| July 08, 2026 | 1.628 |
| July 07, 2026 | 1.680 |
| July 06, 2026 | 1.694 |
| July 02, 2026 | 1.539 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| LataMed AI Corp. | 9.736 |
| SCWorx Corp. | 0.0386 |
| GoodRx Holdings, Inc. | 1.817 |
| Claritev Corp. | -- |
| iSpecimen, Inc. | 1.298 |
Price to Book Value Related Metrics
| PS Ratio | 0.4322 |
| PEG Ratio | -0.0033 |
| Price to Free Cash Flow | 19.28 |
| Price | 1.755 |
| Earnings Yield | -209.4% |
| Market Cap | 130.92M |
| PEGY Ratio | -0.0033 |